C82.26
Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of cancer that originates in the lymphatic system, specifically affecting lymphocytes, which are white blood cells integral to the immune system. Grade III indicates a more aggressive form of this lymphoma, characterized by abnormal cell growth. This particular diagnosis pertains to cases where the affected lymph nodes are located within the pelvic region. Recognizing and understanding this condition is crucial for timely medical intervention and management.
Causes & Symptoms
Clinical Causes: Genetic mutations in lymphocytes leading to uncontrolled growth Age-related changes in immune system function Certain infections or environmental exposures that may trigger abnormal cell proliferation Family history of lymphoma or other blood cancers
Key Symptoms: Swelling or painless lumps in the pelvic area Unexplained weight loss Persistent fatigue or weakness Fever and night sweats Abdominal discomfort or fullness Unusual infections due to compromised immunity
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma involves a combination of clinical evaluation and laboratory tests. Medical professionals typically perform a physical examination to detect swollen lymph nodes in the pelvic region. Confirmatory diagnosis requires tissue biopsy, where a sample of lymph node tissue is examined microscopically for characteristic cancer cells. Additional tests such as blood tests, imaging scans (CT, PET), and bone marrow biopsies may be used to determine the extent and stage of the disease, that is, whether it has spread beyond the lymph nodes.
Treatment Protocols: Managing follicular lymphoma grade III usually involves a multidisciplinary approach. Treatment options can include chemotherapy, targeted therapy, immunotherapy, radiation therapy, or a combination thereof. The choice of treatment depends on various factors including the stage of the disease, patient's overall health, and specific characteristics of the lymphoma. In some cases, a 'watch and wait' approach may be adopted initially, especially if the disease is slow-growing and not causing symptoms. Regular follow-up and monitoring are essential to assess treatment response and adjust strategies accordingly.
Clinical Advice & FAQs
Billing Guidance
Is C82.26 a billable ICD-10 code?
Yes, C82.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.26?
Clinical documentation must specify the nature of Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference